Archives

by in
Entry Author Date Location
Overstreet, Winner in Startup Tax Battle, Gets $2M for AdverseEvents 04/16/14 San Francisco
Spero Emerges With $3M, Backing From Roche, & Plans to Disarm Bugs 04/09/14 Boston
Biogen, Eisai Join Up in Alzheimer’s Drug Pact 03/05/14 Boston
Revamped Radius Health Looks to Cash In With $86M IPO 02/27/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Hunting For Brain Plaques, Neurophage Turns to a Virus 01/31/14 Boston
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
Moderna, Living a Charmed Life, Pulls in Another $125M From Alexion 01/13/14 Boston
Alkermes Nabs $250M It Doesn’t Need, But Could Fend Off Barbarians 01/13/14 Boston
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
Flexion Files for IPO, Seeks $86M to Develop Osteoarthritis Drugs 01/08/14 Boston
East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More 12/20/13 Boston
Radius Health Churns Through 3 CEOs, as Osteoporosis Drug Delayed 12/20/13 Boston
Hologic Names New CEO, Cuts Deal With Icahn to Avoid Proxy Fight 12/09/13 Boston
5AM Ventures, an Early Stage Biotech VC Still Standing, Raises $250M 12/04/13 San Francisco
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
Hologic, Fending off Icahn, Adopts Poison Pill to Deflect Takeover 11/21/13 Boston
Moderna Vacuums Up Another $110M to Make Messenger RNA Drugs 11/20/13 Boston
9 Takeaways from Boston’s Life Science Disruptors 10/04/13 Boston
East Coast Life Sciences Roundup: Moderna, Inotek, Roche, & More 10/04/13 Boston
Moderna Snags $25M DARPA Grant to Fight Pandemics With mRNA Drugs 10/02/13 Boston
The Pharma Bureaucracy Index: Who’s Nimble, and Who’s Sloooowww? 09/30/13 National
X-Chem, Aiming For Tough-to-Drug Targets, Cuts Deal With AstraZeneca 09/25/13 Boston
Foundation Medicine Scores $106M in Upsized IPO 09/24/13 Boston
Langer’s Bind Therapeutics Prices IPO at $15 Per Share 09/20/13 Boston
East Coast Life Sciences Roundup: Genocea, Biogen, OvaScience, & More 09/13/13 Boston
Broad Institute Joins up with Bayer to Find Targeted Cancer Drugs 09/10/13 Boston
Disappointments, New Prospects for Rigel Pharmaceuticals 09/10/13 San Francisco
Sage Taps Former Shire Exec to Lead CNS Drugs Into Clinical Trials 08/14/13 Boston
Buoyed by Partnerships, Bind Therapeutics Floats $80.5M IPO Plan 08/12/13 Boston
Page 1 of 6 next page »